tradmap

AUTL Earnings Autolus Therapeutics plc

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$2 -$1 $0 2021 2022 2022 2022 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $38M $75M 2017 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$288M -$144M $0 2017 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$1 -$0 $0 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26
EPS
Revenue (quarterly)
$0 $23M $46M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$90M -$45M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–19 of 19
Q2 20262026-06-30-0.422026-08-1110-Q
Q1 20262026-03-31-0.272026-05-1410-Q
FY 20252025-12-31-1.082026-03-2710-K
Q3 20252025-09-30-0.742025-11-1210-Q
Q2 20262025-06-30-0.442026-08-1110-Q
Q1 20262025-03-31-0.262026-05-1410-Q
FY 20252024-12-31-0.862026-03-2710-K
Q3 20252024-09-30-0.772025-11-1210-Q
Q2 20252024-06-30-0.432025-08-1210-Q
Q1 20252024-03-31-0.242025-05-0810-Q
FY 20242023-12-31-1.202025-03-2010-K
Q3 20242023-09-30-0.752024-11-1210-Q
Q2 20242023-06-30-0.492024-08-0810-Q
Q1 20242023-03-31-0.232024-05-1710-Q
FY 20232022-12-31-1.572024-03-2110-K
FY 20232022-09-30-0.472024-03-2110-K
FY 20232022-06-30-0.462024-03-2110-K
FY 20232022-03-31-0.412024-03-2110-K
FY 20232021-12-31-1.972024-03-2110-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.